title: [Experimental study on NK cells promoting donor marrow engraftment and hematopoietic reconstitution after MHC haploidentical BMT in mice].
abstract: OBJECTIVE
  To explore the effect of donor-derived NK cells added to pretreatment conditioning regimen on hematopoietic reconstitution after MHC haplotype-mismatched BMT in mice.
  
  
  METHODS
  Murine model of MHC haplotype-mismatched BMT was established by using BALB/c(H-2d) x C57BL/6(H-2b) (CB6F(1)(H-2d/b)) mouse as recipient, and C57BL/6(H-2b) mouse as donor. Fifty recipient mice were divided into 5 groups. The mice in the first three groups were each infused 1 x 10(6), 5 x 10(5), 2 x 10(5)/mouse donor-derived NK cells, respectively before TBI ((60)Co, 9.0 Gy) and then conditioned with TBI, followed by infusion of C57BL/6(H-2b) mice bone marrow cells four hours later. The mice in the fourth group received TBI only, and in the fifth group, TBI and BMT at the some doses as the first three groups. Hematopoietic reconstitution, survival time, body weight, histopathology of the recipients were followed up.
  
  
  RESULTS
  (1) Survival time was (5.15 +/- 0.66) days for the fourth group, and > 30 days for the other 4 groups. (2) Leukocyte and platelet counts at day 10 after BMT were (0.99 +/- 0.22) x 10(9)/L and (61.0 +/- 7.27) x 10(9)/L respectively for the fifth group and (2.01 +/- 0.21) x 10(9)/L, (101.50 +/- 16.34) x 10(9)/L; (1.98 +/- 0.29) x 10(9)/L, (99.50 +/- 16.41) x 10(9)/L and (1.97 +/- 0.21) x 10(9)/L, (98.0 +/- 16.19) x 10(9)/L for the first three groups, respectively. Histopathology displayed no GVHD in all the groups.
  
  
  CONCLUSIONS
  Donor-derived NK cells could promote hematopoietic reconstitution after MHC haplotype-mismatched BMT in mice.
authors.affiliation: The Department of Hematology, the Zhujiang Hospital of the First Military University, Guangzhou 510282, China.
authors.forename: Chun-yan
authors.initials: CY
authors.lastname: Wang
authors.forename: Kun-yuan
authors.initials: KY
authors.lastname: Guo
authors.forename: Bing-yi
authors.initials: BY
authors.lastname: Wu
authors.forename: Lan-xiao
authors.initials: LX
authors.lastname: Wu
authors.forename: Zhen-yu
authors.initials: ZY
authors.lastname: Jiang
authors.forename: Xing-hua
authors.initials: XH
authors.lastname: Pan
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation; D005260:Female; D006085:Graft Survival; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control; D006239:Haplotypes; D006650:Histocompatibility Testing; D007694:Killer Cells, Natural / Q000166:cytology / Q000276:immunology*; D017710:Lymphocyte Transfusion; D008285:Major Histocompatibility Complex / Q000276:immunology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous